Statins are associated with lower risk of gastrointestinal bleeding in patients with unstable coronary syndromes: Analysis of the Orbofiban in Patients with Unstable coronary Syndromes-Thrombolysis In Myocardial Infarction 16 (OPUS-TIMI 16) trial

American Heart Journal

Volumn 151, Issue 5, 2006, Pages 976.e1-976.e6

  Atar, Shaul ^a   Cannon, Christopher P ^b   Murphy, Sabina A ^b   Rosanio, Salvatore ^a   Uretsky, Barry F ^a   Birnbaum, Yochai ^a  

^a University of Texas Medical Branch School of Medicine   (United States)

^b BRIGHAM AND WOMEN S HOSPITAL   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ACETYLSALICYLIC ACID; ANTILIPEMIC AGENT; CALCIUM CHANNEL BLOCKING AGENT; DIURETIC AGENT; FIBRINOGEN RECEPTOR ANTAGONIST; HYDROXYMETHYLGLUTARYL COENZYME A REDUCTASE INHIBITOR; ORBOFIBAN; PLACEBO;

ACUTE CORONARY SYNDROME; ADULT; AGE DISTRIBUTION; AGED; ANAMNESIS; ARTICLE; BLOOD CLOT LYSIS; CEREBROVASCULAR ACCIDENT; COMPARATIVE STUDY; CONTROLLED STUDY; DATA ANALYSIS; DISEASE SEVERITY; FEMALE; FOLLOW UP; GASTROINTESTINAL HEMORRHAGE; HEART INFARCTION; HOSPITAL ADMISSION; HUMAN; LOGISTIC REGRESSION ANALYSIS; MAJOR CLINICAL STUDY; MALE; PRIORITY JOURNAL; RETROSPECTIVE STUDY; RISK FACTOR;

EID: 33646119399     PISSN: 00028703     EISSN: 10976744     Source Type: Journal    
DOI: 10.1016/j.ahj.2006.02.013     Document Type: Article

References (12)

1. Law M.R., Wald N.J., and Rudnicka A.R. Quantifying effect of statins on low density lipoprotein cholesterol, ischaemic heart disease, and stroke: systematic review and meta-analysis. BMJ 326 (2003) 1423
2. LaRosa J.C., He J., and Vupputuri S. Effect of statins on risk of coronary disease: a meta-analysis of randomized controlled trials. JAMA 282 (1999) 2340-2346
3. Davignon J. Beneficial cardiovascular pleiotropic effects of statins. Circulation 109 Suppl 1 (2004) III39-III43
4. Wainwright C.L. Statins-is there no end to their usefulness?. Cardiovasc Res 65 (2005) 296-298
5. Undas A., Celinska-Lowenhoff M., Kaczor M., et al. New nonlipid effects of statins and their clinical relevance in cardiovascular disease. Thromb Haemost 91 (2004) 1065-1077
6. Birnbaum Y., Ye Y., Rosanio S., et al. Prostaglandins mediate the cardioprotective effects of atorvastatin against ischemia-reperfusion injury. Cardiovasc Res 65 (2005) 345-355
7. Cannon C.P., McCabe C.H., Wilcox R.G., et al. Oral glycoprotein IIb/IIIa inhibition with orbofiban in patients with unstable coronary syndromes (OPUS-TIMI 16) trial. Circulation 102 (2000) 149-156
8. Moscucci M., Fox K.A., Cannon C.P., et al. Predictors of major bleeding in acute coronary syndromes: the Global Registry of Acute Coronary Events (GRACE). Eur Heart J 24 (2003) 1815-1823
9. Undas A., Brummel-Ziedins K.E., and Mann K.G. Statins and blood coagulation. Arterioscler Thromb Vasc Biol 25 (2005) 287-294
10. Schonbeck U., and Libby P. Inflammation, immunity, and HMG-CoA reductase inhibitors: statins as antiinflammatory agents?. Circulation 109 Suppl 1 (2004) II18-II26
11. Chen J.C., Huang K.C., Wingerd B., et al. HMG-CoA reductase inhibitors induce COX-2 gene expression in murine macrophages: role of MAPK cascades and promoter elements for CREB and C/EBPbeta. Exp Cell Res 301 (2004) 305-319
12. Russell R.I. Protective effects of the prostaglandins on the gastric mucosa. Am J Med 81 (1986) 2-4